GlaxoSmithKline shuts down plant over legionnaires' bacteria

Pharmaceutical giant GlaxoSmithKline has shut down a US plant that produces inhaled medications after discovering the bacteria that causes Legionnaires’ disease.
The manufacturing plant in Zebulon, about 25 miles east of Raleigh, North Carolina, was closed after routine testing found the bacteria in a self-standing cooling tower.